論文

奥野Gメンバーの研究論文が発表されました

Inoue M, Ekimoto T, Yamane T, Ikeguchi M, Computational Analysis of Activation of Dimerized Epidermal Growth Factor Receptor Kinase Using the String Method and Markov State Model, Journal of chemical information and modeling, 2024;64(9):3884-3895, 2024/4/26, doi:10.1021/acs.jcim.4c00172

奥野Gメンバーの研究論文が発表されました

Ikeda, S., Sakata, A., Arakawa, Y., Mineharu, Y., Makino, Y., Takeuchi, Y., Fushimi, Y., Okuchi, S., Nakajima, S., Otani, S., & Nakamoto, Y., Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation, Neuroradiology, 2024;66(6):973-981, 2024/4/24, doi:10.1007/s00234-024-03361-8

奥野Gメンバーの研究論文が発表されました

Mori S, Izumi H, Araki M, Liu J, Tanaka Y, Kagawa Y, Sagae Y, Ma B, Isaka Y, Sasakura Y, Kumagai S, Sakae Y, Tanaka K, Shibata Y, Udagawa H, Matsumoto S, Yoh K, Okuno Y, Goto K, Kobayashi SS., LTK mutations responsible for resistance to lorlatinib in non-small cell lung cancer harboring CLIP1-LTK fusion, Communications biology, 2024;7(1):412, 2024/4/4, doi:10.1038/s42003-024-06116-6

奥野Gメンバーの研究論文が発表されました

Hiroaki Iwata*, Yoshihiro Hayashi*, Takuto Koyama, Aki Hasegawa, Kosuke Ohgi, Ippei Kobayashi, Yasushi Okuno, Feature extraction of particle morphologies of pharmaceutical excipients from scanning electron microscope images using convolutional neural networks, International Journal of Pharmaceutics, 22024;653:123873, 2024/3/25, doi:10.1016/j.ijpharm.2024.123873

Yamane T, Nakayama T, Ekimoto T, Inoue M, Ikezaki K, Sekiguchi H, Kuramochi M, Terao Y, Judai K, Saito M, Ikeguchi M, C. Sasaki Y ,Comparison of the Molecular Motility of Tubulin Dimeric Isoforms: Molecular Dynamics Simulations and Diffracted X-ray Tracking Study, International Journal of Molecular Sciences , 2,415,423,2023/10/2, https://www.mdpi.com/1422-0067/24/20/15423

Echizen H, Hanaoka K, Shimamoto K, Hibi R, Toma-Fukai S, Ohno H, Sasaki E, Komatsu T, Ueno T, Tsuchiya Y, Watanabe Y, Otsuka T, Saito H, Nagatoishi S, Tsumoto K, Kojima H, Okabe T, Shimizu T, Urano Y,”Discovery of a cystathionine γ-lyase (CSE) selective inhibitor targeting active-site pyridoxal 5′-phosphate (PLP) via Schiff base formation”, Scientific Reports  ,1,316,456,2023/9/30,  https://doi.org/10.1038/s41598-023-43536-6

Okamoto R,Kojima R, Nakatsui M , Toward AI-supported evaluation for safety control measures against near-miss events in pharmaceutical products , Safety Science , Volume 168,106314 , 2023/12/1 , doi.org/10.1016/j.ssci.2023.106314

Hattori EY, Arakawa Y, Mineharu Y, Furukawa K, Terada Y, Yamao Y, Tanji M, Kikuchi T, Miyamoto S. , Seizure control by adding on other anti-seizure medication on seizure during levetiracetam administration in patients with glioma-related epilepsy.  , BMC Cancer  , 23, 849 , 2023/9/11 , doi.org/10.1186/s12885-023-11273-8

Nakamura K, Uchino E, Sato N, Araki A, Terayama K, Kojima R, Murashita K, Itoh K, Mikami T, Tamada Y, Okuno Y , Individual health-disease phase diagrams for disease prevention based on machine learning , Journal of Biomedical Informatics , 144,104448 , 2023/8/23 , doi.org/10.1016/j.jbi.2023.104448

Matsuoka T, Hattori A, Oishi S, Araki M, Biao Ma, Fujii T, Arichi N, Okuno Y, Kakeya H, Yamasaki S, Ohno H, Inuki S , Establishment of an MR1 Presentation Reporter Screening System and Identification of Phenylpropanoid Derivatives as MR1 Ligands. , Journal of medicinal chemistry , 66(17),12520–12535 , 2023/8/23 , doi.org/10.1021/acs.jmedchem.3c01122